Antihemophilic factor viii and von willebrand factor (Intravenous)

Medically reviewed by Drugs.com. Last updated on May 30, 2022.

Commonly used brand name(s)

In the U.S.

• Alphanate
• Humate-P
• Wilate

Available Dosage Forms:

• Powder for Solution

Therapeutic Class: Antihemophilic Agent

Uses for antihemophilic factor viii and von willebrand factor

Antihemophilic factor VIII and von Willebrand factor injection is a combination product that is used to treat serious bleeding episodes in patients with a bleeding problem called von Willebrand disease (VWD). The bleeding episode may be related to an injury (trauma) or a surgical procedure. Antihemophilic factor viii and von willebrand factor may also be used to stop bleeding, and to control and prevent bleeding episodes in patients with hemophilia A.

Antihemophilic factor VIII and von Willebrand factor are normally produced in the body. They help clot the blood when an injury occurs. Patients with von Willebrand disease or hemophilia A do not make enough of these substances to prevent bleeding, so this product is given to increase the levels of these substances in the blood.

Antihemophilic factor viii and von willebrand factor is available only with your doctor's prescription.

Before using antihemophilic factor viii and von willebrand factor

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For antihemophilic factor viii and von willebrand factor, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to antihemophilic factor viii and von willebrand factor or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of antihemophilic factor VIII and von Willebrand factor injection in children with von Willebrand disease, and in teenagers with hemophilia A.

Geriatric

Adequate and well-controlled studies have not been done on the relationship of age to the effects of antihemophilic factor VIII and von Willebrand factor injection in geriatric patients.

Breastfeeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.

Interactions with food/tobacco/alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to oc...